Log in to save to my catalogue

Developing benzylisoquinoline alkaloid-enriched opium poppy via CRISPR-directed genome editing: A re...

Developing benzylisoquinoline alkaloid-enriched opium poppy via CRISPR-directed genome editing: A re...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8c52004ca4aa4c12a8313c71d1272a1d

Developing benzylisoquinoline alkaloid-enriched opium poppy via CRISPR-directed genome editing: A review

About this item

Full title

Developing benzylisoquinoline alkaloid-enriched opium poppy via CRISPR-directed genome editing: A review

Publisher

England: BioMed Central Ltd

Journal title

BMC plant biology, 2024-07, Vol.24 (1), p.700-700, Article 700

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Among plant-derived secondary metabolites are benzylisoquinoline alkaloids (BIAs) that play a vital role in medicine. The most conspicuous BIAs frequently found in opium poppy are morphine, codeine, thebaine, papaverine, sanguinarine, and noscapine. BIAs have provided abundant clinically useful drugs used in the treatment of various diseases and ai...

Alternative Titles

Full title

Developing benzylisoquinoline alkaloid-enriched opium poppy via CRISPR-directed genome editing: A review

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8c52004ca4aa4c12a8313c71d1272a1d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8c52004ca4aa4c12a8313c71d1272a1d

Other Identifiers

ISSN

1471-2229

E-ISSN

1471-2229

DOI

10.1186/s12870-024-05412-x

How to access this item